About Biocon Limited India
Biocon Limited India is a leading biopharmaceutical company that has been at the forefront of innovation in the industry. The company is fully integrated and has developed a reputation for producing affordable biosimilars, novel biologics, and complex APIs.
Founded in 1978 by Kiran Mazumdar-Shaw, Biocon Limited India has grown to become one of the most respected names in the biopharmaceutical industry. The company's mission is to make healthcare accessible and affordable to all, and it achieves this through its commitment to research and development.
One of Biocon's key strengths is its expertise in biosimilars. Biosimilars are biological products that are similar but not identical to an existing approved reference product. They offer a more cost-effective alternative to expensive branded drugs while maintaining high levels of safety and efficacy.
Biocon has developed several biosimilar products that have been approved by regulatory authorities around the world. These include insulin glargine, trastuzumab, adalimumab, bevacizumab, pegfilgrastim, etanercept, rituximab among others.
In addition to biosimilars, Biocon also develops novel biologics - new drugs that are based on biological molecules such as proteins or antibodies. These drugs have shown great promise in treating diseases such as cancer and autoimmune disorders.
The company's research efforts are supported by state-of-the-art facilities located across India including Bangalore (Karnataka), Hyderabad (Telangana), Visakhapatnam (Andhra Pradesh) & Chennai (Tamil Nadu). These facilities house some of the most advanced equipment available for drug discovery and development.
Biocon also places great emphasis on quality control throughout its manufacturing process. The company adheres strictly to international standards such as Good Manufacturing Practices (GMP) ensuring that all products meet stringent quality requirements before they reach patients.
Another area where Biocon excels is complex APIs - active pharmaceutical ingredients used in making finished dosage forms like tablets or capsules. Complex APIs require specialized knowledge due to their complexity which makes them difficult for other companies without expertise in this area.
The company's commitment towards sustainability can be seen through various initiatives like reducing carbon footprint through green energy sources & water conservation measures at their manufacturing sites across India
Overall Biocon Limited India stands out from other companies due its focus on innovation-led approach towards developing affordable medicines with high-quality standards which makes it one of the best choices for patients worldwide who need access life-saving treatments at an affordable price point without compromising on quality or safety standards
biocon.com
